Tobacco Center Faculty Blog

June 22, 2013

Stanton A. Glantz, PhD

Gary Fooks and Anna Gilmore just published a very important paper on how the pending Trans-Pacific Partnership (TPP) trade agreement could undermine tobacco control policies in countries including 40% of the world's population.

Their paper focuses on using the TPP to block plain packaging, but the concerns they raise apply to all tobacco control policies, all the way down to local clean indoor air laws and tobacco taxes.  Indeed, the issues they raise apply to any health or environmental law that might make transnational corporations less profitable.

This paper is must reading for anyone interested to tobacco control or public and environmental health generally.  It raises serious questions about the lack of transparency of the process by which the TPP is being negotiated and the preferential access to the negotiating process that multinational corporations, including multinational tobacco corporations, have.  A logical conclusion of the information in this paper is that the negotiating process needs to be opened up to public scrutiny.

Given the tremendous impact that trade agreements like the TPP could have on all aspects of life, I do not understand why they are not considered treaties, which would require a 2/3 vote in the US Senate for ratification. 

June 18, 2013

Stanton A. Glantz, PhD

I just submitted the following public comment to the FDA

COMMENT ON CITIZEN PETITION ASKING THE U.S. FOOD AND DRUG ADMINISTRATION TO
PROHIBIT MENTHOL AS ACHARACTERIZING FLAVOR IN CIGARETTES[*]

Docket ID: FDA-2013-P-0435
June 19, 2013

            Rather than prohibiting the use of menthol “as a characterizing flavor” are requested in the Citizen Petition, the FDA should simply prohibit the use of menthol (and menthol analogs) in cigarettes and, as it asserts jurisdiction over other tobacco products, those products as well.

            There are two reasons for pursuing a prohibition.

June 6, 2013

Stanton A. Glantz, PhD

Mitch Zeller, Director of the FDA Center for Tobacco Products, will be the keynote speaker for the 2014 UCSF "It's About a Billion Lives" symposium, to be held on the UCSF Parnassus campus from 8:30 am until 1:00 pm on Friday, January 31, 2014.

You can view the 2013 and 2012 symposia here.

June 4, 2013

Stanton A. Glantz, PhD

Stanton Glantz, Professor of Medicine and Director of the UC San Francisco Center for Tobacco Control Research and Education is seeking an individual interested in conducting a broad range of research projects related to tobacco control.  These include: (1) State and local policymaking process as it relates to tobacco control. The project involves preparing detailed case studies on tobacco policy making in different states, including research on the development and passage (or defeat) of state and local tobacco control legislation, funding and management of tobacco control programs, efforts of public health advocates to promote public health programs, and opposition to tobacco control by the tobacco industry and its allies and surrogates; and (2) Statistical and economic analysis of tobacco control programs and related issues. Data collection will involve researching written records, analyzing campaign contribution information, conducting interviews and doing field research.

June 3, 2013

Stanton A. Glantz, PhD

Reuters reports that France will treat e-cigs the same as conventional cigarettes in terms of use in public places.  It will also include them in the ad ban on tobacco products.  This is a logical step that will protect bystanders from the toxic chemicals that e-cigarettes emit (albeit lower levels of toxic chemicals than super-polluting conventional cigarettes) that e-cigs emit.

As with a similar law the California State Senate just passed, this is a sensible step that does not prohibit people from using e-cigarettes in ways that do not impact other people.

Meanwhile, some venues, including San Francisco's baseball stadium, are acting to protect their patrons from e-cig emissions:

Pages